Cited by 30Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

Unraveling the Molecular Mechanisms Behind the Metabolic Basis of Sporadic Alzheimer's Disease

Erol, Adnan·2008·Journal of Alzheimer's Disease

Abstract

Peripheral insulin resistance is associated with hyperinsulinemia, which may be associated with brain insulin deficiency that is characteristic of sporadic Alzheimer's disease (sAD). Oxidative insult, which is the result of insulin associated disordered brain energy metabolism, is a significant early event in the pathological cascade of sAD. Aggregation of disease-specific proteins such as amyloid-beta and tau may act as a compensatory response against the oxidative insult at the early periods. In the later stages, oxidative stress stimulates c-Jun N-terminal kinase (JNK) activation. The deficient insulin signaling is ultimately linked to protein kinase B (Akt) pathway and subsequently glycogen synthase kinase-3 (GSK3) and forkhead transcription factors (FOXO). Peripheral insulin resistance related intense interactions between JNK, GSK3, FOXO factors, and p53, which may lead to apoptotic neuronal death, are outlined in a postulate. In light of this postulate, the importance of detailed knowledge of these common physiological processes for the opportunities of treatment that could prevent or reduce the onset of sAD is discussed as well.

Integrity signals

Registry

Crossref · 10.3233/jad-2009-1047

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Erol, A.
Affiliations
Tekirdağ Namık Kemal University (TR)
Corresponding author
Erol, Adnan
Venue
Journal of Alzheimer's Disease
Published
2008-11-30
Volume
17
Issue
2
Pages
267-276
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W1534612161
Cited by
30
References
3
Citations by year
2026: 2 · 2025: 1 · 2021: 1 · 2019: 1 · 2018: 1 · 2014: 3 · 2013: 1 · 2012: 5
FWCI
3.38
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Alzheimer s Disease (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
sporadic Alzheimer's disease, peripheral insulin resistance
MeSH terms
Alzheimer Disease, Animals, Humans, Insulin, Insulin Resistance, Metabolic Diseases, Signal Transduction, Amyloid beta-Peptides, Glycogen Synthase Kinase 3, JNK Mitogen-Activated Protein Kinases, Forkhead Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review